|
Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies Clinical research trials and Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies. Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies clinical trial. Test subjects typically receive the most expert healthcare available for their Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies  Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies
Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies
For Condition: Breast Neoplasms,Lung Neoplasms,Multiple Myeloma,Leukemia, Lymphocytic, Chronic,Lymphomas
Status: Completed
Sponsor(s): Amgen ,
Synopsis: Chemotherapy can often cause anemia in patients with cancer. Anemia is a low number of red blood cells. The symptoms of anemia may include fatigue, dizziness, headache, chest pain, and shortness of breath. Erythropoietin is a hormone made by the kidneys that signals the bone marrow to produce more red blood cells. Recombinant human erythropoietin has been produced in the laboratory and has the same effect as the hormone produced by the body. Use of recombinant human erythropoietin allows the body to produce more red blood cells, possibly eliminating or decreasing your symptoms and the need for a red blood cell transfusion. Recombinant human erythropoietin is FDA approved to treat anemia in cancer patients receiving chemotherapy. This clinical study is investigating the effectiveness of darbepoetin alfa for the treatment of anemia in patients with non-myeloid malignancies who are receiving chemotherapy every three weeks. Darbepoetin alfa is a recombinant erythropoietic protein that stimulates the production of red blood cells. This medication has not been approved to treat cancer patients with anemia, however it has been approved by the FDA to treat chronic renal failure patients with anemia.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - Patients with non-myeloid malignancies - Patients receiving at least 12 weeks of chemotherapy on a 3-week cycle schedule - Patients with anemia (hgb >/= 9.0 and
Total Enrollment:
Location and Contact Information:
Research Center
Philadelphia, Pennsylvania,
United States
Additional Information:
Study ID Numbers: 20010162;
Study Start Date:
Record last reviewed: January 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00036023
Other Multiple Myeloma Studies:
1. Total Therapy II
2. Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
3. CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation
4. Thalidomide-Dexamethasone for Multiple Myeloma
5. Blood and Marrow Transplant Clinical Research Network
Related Studies:
Other Multiple Myeloma Clinical Trials
Other Pennsylvania Clinical Trials
Other Philadelphia Clinical Trials
Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies
|
|
|
|
|
|
|
|
